Cystic Fibrosis: A Review.
Ong T, Ramsey BW.
JAMA. 2023 Jun 6;329(21):1859-1871. doi: 10.1001/jama.2023.8120.
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial.
Hoppe JE, Kasi AS, Pittman JE, Jensen R, Thia LP, Robinson P, Tirakitsoontorn P, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Salinas DB, Zhu J, Chen YC, Rodriguez-Romero V, Sosnay PR, Davies G; VX21-121-105 Study Group.
Lancet Respir Med. 2025 Mar;13(3):244-255. doi: 10.1016/S2213-2600(24)00407-7. Epub 2025 Jan 2.
Pulmonary aspergillosis: a clinical review.
Kousha M, Tadi R, Soubani AO.
Eur Respir Rev. 2011 Sep 1;20(121):156-74. doi: 10.1183/09059180.00001011.
Cystic fibrosis: new challenges and perspectives beyond elexacaftor/tezacaftor/ivacaftor.
Terlizzi V, Lopes-Pacheco M.
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251323194. doi: 10.1177/17534666251323194. Epub 2025 Mar 31.
CFTR Modulators: Current Status and Evolving Knowledge.
Regard L, Martin C, Da Silva J, Burgel PR.
Semin Respir Crit Care Med. 2023 Apr;44(2):186-195. doi: 10.1055/s-0042-1758851. Epub 2022 Dec 19.
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis.
Agarwal R, Muthu V, Sehgal IS.
Semin Respir Crit Care Med. 2024 Feb;45(1):114-127. doi: 10.1055/s-0043-1776912. Epub 2023 Dec 28.
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.
Lopes-Pacheco M.
Front Pharmacol. 2020 Feb 21;10:1662. doi: 10.3389/fphar.2019.01662. eCollection 2019.
A new era for people with cystic fibrosis.
Bierlaagh MC, Muilwijk D, Beekman JM, van der Ent CK.
Eur J Pediatr. 2021 Sep;180(9):2731-2739. doi: 10.1007/s00431-021-04168-y. Epub 2021 Jul 2.
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation.
Wine E, Aloi M, Van Biervliet S, Bronsky J, di Carpi JM, Gasparetto M, Gianolio L, Gordon H, Hojsak I, Hudson AS, Hussey S, van Limbergen J, Miele E, Norsa L, Olén O, Pellino G, van Rheenen P, de Ridder L, Russell RK, Shouval DS, Trindade E, Turner D, Wilson DC, Yerushalmy Feler A, Assa A.
J Pediatr Gastroenterol Nutr. 2025 Sep;81(3):765-815. doi: 10.1002/jpn3.70097. Epub 2025 Jul 18.
Gastrointestinal Burden in Patients With Pancreatic Insufficient Cystic Fibrosis Before and After Elexacaftor/Tezacaftor/Ivacaftor Use.
Abi-Aad SJ, Trocchia C, Mosha M, Mark JA, Leung DH, Khalaf R.
Pancreas. 2025 Nov-Dec 01;54(10):e858-e862. doi: 10.1097/MPA.0000000000002522. Epub 2025 Jun 23.
